A randomized clinical control study of mustha-amalaki siddha takradhara in management of rajoniwritti with special reference to menopausal stress

A randomized clinical control study of musthaâ??amalaki siddha takradhara in management of rajonivritti with special reference to stress

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/05/033698

Enrollment

Registered

2021-05-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F411- Generalized anxiety disorder

Interventions

Intervention1: Musthaâ??amalaki siddha takradhara in mangement of rajonivritti with special reference to stress: Mustha-amalaki siddha takradhara 7 days for 30 mins Control Intervention1: Jatamansi ph

Eligibility

Inclusion criteria

Inclusion criteria: Patient between age 35 to 55 years of females shows classical sings and symptoms of Rajonivritti stress patient having stress hot flushes, anxiety, vaginal dryness, loss of libido, insomnia, mood swings.

Exclusion criteria

Exclusion criteria: Patients with the history of systemic disorders, infections & under anti psychotic drugs Patients on HRT (Harmone Replacement Therapy) Crippling conditions like malignancy chronic disorders, R. A., Coronary artery disease etc.

Design outcomes

Primary

Measure	Time frame
To study the the efficacy of Mustha â?? Amalaki Siddha Takradhara In Mangement Of Rajonivritti With Special Reference To Stress by Stress scaleTimepoint: 18 months Lakshana- 1 Hot Flushes 2 Anxiety 4 Vaginal Dryness 5 Loss of libido 6 Insomnia 7 Mood-swing 8 Sleeplessnes 9 Headache	—

Secondary

Measure	Time frame
To study the mode of action of Mustha â?? Amalaki Siddha Takradhara By using siddha takradhara for patients and see the results by analysis of mood,sleep , behaviour changes of patients etc.Timepoint: 7 days Lakshana 1 Hot Flushes 2 Anxiety 4 Vaginal Dryness 5 Loss of libido 6 Insomnia 7 Mood-swing 8 Sleeplessness 9. Headache Discussion	—

Countries

India

Contacts

Public ContactDr Alakananda Kulkarni

annasaheb dange ayurved medical college ashta

vdalaknandakulkarni@gmail.com9860359489

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026